文献速递生殖医学

高糖基化人绒毛膜促性腺激素作为持续妊娠的预测指标

Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy.
PubMed 文献 · Am J Obstet Gynecol · 2019-08-08

在接受新鲜或冻融体外受精周期、自体第5天单胚胎移植且血清人绒毛膜促性腺激素>3 mIU/mL的115名女性中,移植后11天检测高糖基化人绒毛膜促性腺激素与总人绒毛膜促性腺激素高度相关(Pearson相关系数92.14,P<.0001);持续妊娠与临床妊娠丢失相比,仅平均高糖基化人绒毛膜促性腺激素及其占总人绒毛膜促性腺激素比例显著更高,总人绒毛膜促性腺激素无显著差异。

要点

  • 移植后11天高糖基化人绒毛膜促性腺激素与总人绒毛膜促性腺激素高度相关(Pearson相关系数92.14,P<.0001)。
  • 持续妊娠与临床妊娠丢失相比,平均高糖基化人绒毛膜促性腺激素显著更高(19.0 vs 12.2 ng/mL,β -8.1,95%CI -13.0至-3.2)。
  • 高糖基化人绒毛膜促性腺激素占总人绒毛膜促性腺激素比例在持续妊娠与临床妊娠丢失间有显著差异(4.6% vs 4.1%;风险比0.79;95%CI 0.66-0.94)。

核心结论

  • 单囊胚移植后11天检测,高糖基化人绒毛膜促性腺激素与总人绒毛膜促性腺激素高度相关,但仅平均高糖基化人绒毛膜促性腺激素及其与总人绒毛膜促性腺激素的比值在持续妊娠与临床妊娠丢失间显著更高。
  • 需要进一步评估高糖基化人绒毛膜促性腺激素,包括在多胚胎移植和多胎妊娠中以及使用连续测量。

研究设计与样本

  • 在大学附属不孕症诊所接受新鲜或冻融体外受精周期、自体第5天单胚胎移植且血清人绒毛膜促性腺激素>3 mIU/mL的女性(n=115)纳入研究。
  • 移植后11天在单一实验室检测人绒毛膜促性腺激素(变异系数<6%),剩余冻存血清(-80℃)送至Quest Laboratories检测高糖基化人绒毛膜促性腺激素(变异系数<9.1%)。
  • 采用预先校正卵母细胞年龄的线性回归分析比较持续妊娠(>8周妊娠)与失败妊娠(临床妊娠丢失、生化妊娠和异位妊娠)中的人绒毛膜促性腺激素和高糖基化人绒毛膜促性腺激素。

主要发现

  • 共有85例妊娠(73.9%)为持续妊娠。
  • 高糖基化人绒毛膜促性腺激素与人绒毛膜促性腺激素值高度相关(Pearson相关系数92.14,P<.0001),且两者的平均值均与囊胚扩张评分正相关(趋势检验P值<.0004)。
  • 持续妊娠与失败妊娠相比,平均人绒毛膜促性腺激素和高糖基化人绒毛膜促性腺激素均显著更高。
  • 持续妊娠与临床妊娠丢失相比,平均高糖基化人绒毛膜促性腺激素显著更高(19.0 vs 12.2 ng/mL,β -8.1,95%置信区间-13.0至-3.2),而人绒毛膜促性腺激素无显著差异。
  • 持续妊娠与临床妊娠丢失相比,高糖基化人绒毛膜促性腺激素占总人绒毛膜促性腺激素比例更高(4.6% vs 4.1%;风险比0.79;95%置信区间0.66-0.94)。

关键数值与推荐

  • 持续妊娠与临床妊娠丢失相比,平均高糖基化人绒毛膜促性腺激素为19.0 vs 12.2 ng/mL(β -8.1,95%置信区间-13.0至-3.2)。
  • 持续妊娠与临床妊娠丢失相比,高糖基化人绒毛膜促性腺激素占总人绒毛膜促性腺激素比例为4.6% vs 4.1%(风险比0.79;95%置信区间0.66-0.94)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步评估高糖基化人绒毛膜促性腺激素,包括在多胚胎移植和多胎妊娠中以及使用连续测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperglycosylated human chorionic gonadotropin, the predominant human chorionic gonadotropin variant secreted following implantation, is associated with trophoblast invasion. OBJECTIVE: To determine whether the initial serum hyperglycosylated human chorionic gonadotropin differs between ongoing and failed pregnancies, and to compare it to total serum human chorionic gonadotropin as a predictor of ongoing pregnancy. MATERIALS AND METHODS: Women undergoing fresh/frozen in vitro fertilization cycles at a university-based infertility clinic with an autologous day 5 single embryo transfer resulting in serum human chorionic gonadotropin >3 mIU/mL (n = 115) were included. Human chorionic gonadotropin was measured 11 days after embryo transfer in a single laboratory (coefficient of variation <6%). Surplus frozen serum (-80oC) was shipped to Quest Laboratories for measurement of hyperglycosylated human chorionic gonadotropin (coefficient of variation <9.1%). Linear regression analyses adjusted for oocyte age a priori were used to compare human chorionic gonadotropin and hyperglycosylated human chorionic gonadotropin in ongoing pregnancies (>8 weeks of gestation) and failed pregnancies (clinical pregnancy loss, biochemical and ectopic pregnancies). RESULTS: A total of 85 pregnancies (73.9%) were ongoing. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin values were highly correlated (Pearson correlation coefficient 92.14, P < .0001), and mean values of both were positively correlated with blastocyst expansion score (P value test for trend < .0004). Mean human chorionic gonadotropin and hyperglycosylated human chorionic gonadotropin were significantly higher in ongoing vs failed pregnancies. Among ongoing pregnancies vs clinical losses, mean hyperglycosylated human chorionic gonadotropin, but not human chorionic gonadotropin, was significantly higher (19.0 vs 12.2 ng/mL, β -8.1, 95% confidence interval -13.0 to -3.2), and hyperglycosylated human chorionic gonadotropin comprised a higher proportion of total human chorionic gonadotropin (4.6% vs 4.1%; risk ratio, 0.79; 95% confidence interval, 0.66-0.94). CONCLUSION: Measured 11 days after single blastocyst transfer, hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin values were highly correlated, but only mean hyperglycosylated human chorionic gonadotropin and its ratio to total human chorionic gonadotropin were significantly higher in ongoing pregnancies vs clinical pregnancy losses. Further evaluation of hyperglycosylated human chorionic gonadotropin, including in multiple embryo transfers and multiple pregnancy, and using serial measurements, is required.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Brady PC, Farland LV, Racowsky C, et al. Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy. Am J Obstet Gynecol. 2019. PMID: 31401260. doi:10.1016/j.ajog.2019.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。